4/A
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0000899243-22-007415
Options or other derivatives
- Chief Scientific Officer acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kalled Susan Chief Scientific Officer | 2022-02-18 | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | D | ||
Loading xslF345X03/doc4a.xml…